Parkinson's Research Found A Potential Treatment Already Used For Cancer
SMRTR summary
Researchers discovered that an existing cancer drug, nivolumab/relatlimab, may effectively treat Parkinson's disease by blocking two proteins that help toxic clumps spread throughout the brain. In mouse studies, the treatment achieved a 90% reduction in the spread of harmful alpha-synuclein proteins that cause Parkinson's progression.
SMRTR provides this summary for quick context. The original article belongs to BGR.
Read the original article